공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

질 슬링 시장 : 성장, 동향, COVID-19의 영향 및 예측(2021-2026년)

Vaginal Slings Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 05월 상품 코드 1008426
페이지 정보 영문
가격
US $ 4,250 ₩ 5,044,000 PDF (Single User License)
US $ 4,750 ₩ 5,637,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,121,000 PDF (Site License)
US $ 7,500 ₩ 8,901,000 PDF (Corporate License)


질 슬링 시장 : 성장, 동향, COVID-19의 영향 및 예측(2021-2026년) Vaginal Slings Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

질 슬링 시장 규모는 예측기간 중 4.6%의 CAGR로 확대될 것으로 예측됩니다.

시장 성장에 기여하는 주요 요인은 요실금 유병률 상승입니다. 요로감염증, 골반저근과 요도괄약근 쇠약, 갱년기 장애, 임신과 출산 등의 많은 요인이 요실금 증상 발증으로 이어집니다. Gothenburg Continence Research Center에 의하면 2018년에는 4억 2,300만명 이상이 요실금이라고 진단되었으며, 그 중 3억 300만명이 여성입니다. 또한 최소침습 수술 수요 증가와 기술 진보 증가는 시장 성장을 지지합니다. 그러나 이러한 디바이스의 인식 결여는 시장 성장을 저해하는 주요 요인이 되고 있습니다.

질 슬링(Vaginal Slings) 시장에 대해 조사했으며, 시장 개요와 함께 제품 종류별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
    • 요실금 이환율 상승과 고령 인구 증가
    • 최소침습 수술과 제품 개발에 대한 수요 증가
  • 시장 성장 억제요인
    • 질병과 관련된 사회적 스티그마와 시술에 의한 위험과 합병증
  • Porter's Five Forces 분석

제5장 시장 세분화

  • 제품 종류별
    • 경폐쇄공 슬링
    • 텐션프리 질 테이프 슬링
    • 기타
  • 최종사용자별
    • 병원
    • 외래 수술 센터
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동과 아프리카
    • 남미

제6장 경쟁 상황

  • 기업 개요
    • Boston Scientific Corporation
    • Coloplast Corp
    • Promedon Group
    • AMI GmbH
    • Johnson &Johnson
    • Betatech Medical
    • Caldera Medical
    • CR Bard Inc.

제7장 시장 기회와 동향

KSM 21.06.18

The vaginal slings market studied was projected to grow with a CAGR of 4.6% over the forecast period. The major factor attributing to the growth of the market is the rising prevalence of urinary incontinence. Numerous factors such as urinary tract infection, weakening of pelvic floor muscles & urethral sphincters, menopause, pregnancy & childbirth lead to the development of urinary incontinence symptoms. According to the Gothenburg Continence Research Center, in 2018 more than 423 million had diagnosed with urinary incontinence of which 303 million are women. Furthermore, rising demand for minimally invasive procedures and increasing technological advancements boost the market growth. However, lack of awareness of these devices is the major drawback of market growth.

Key Market Trends

Transobturator Slings Dominate the Vaginal Slings Market

The dominant share of the segment is due to the advantages of this type of slings over the others, like decreased risk of bladder injury, bowel injury, and major blood vessel injury, ease of the procedure, and efficacy equivalent to tension-free vaginal tape slings. Apart from the benefits of the slings other factors that boost the segment growth are the increasing prevalence of urinary incontinence in women and increasing geriatric population who are more prone to these symptoms. According to the United Nations report, in 2017, women accounted for 54 percent of the global population aged 60 years or over and 61 percent of those aged 80 years or over. Furthermore, the increasing demand for the minimally invasive procedures is propelling the segment growth

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall vaginal slings market, throughout the forecast period. The largest share is mainly due to the presence of a larger patient pool and increasing geriatric population. Furthermore, well-established insurance policies and the availability of advanced healthcare infrastructure are a few of the other factors boosting the market in this region. In the North America region, the United States holds the largest market share due to factors such as the increasing number of geriatric populations, along with a growing number of patient pool in the country. According to the National Association for Incontinence, more than 25 million people in the United States experience bladder leakage every day and of which the major share is held by the women. As per the statistics the large patient pool and high disposable income propels the market growth in the region.

Competitive Landscape

The vaginal slings market moderately competitive and market players focusing on various strategies such as product advancement, invention, acquisitions, and mergers. Some of the companies which are currently dominating the market are Boston Scientific Corporation, Coloplast Corp, Promedon Group, A.M.I. GmbH, Johnson & Johnson, Betatech Medical, Caldera Medical, ABISS.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Urinary Incotinence and Rise in Geriatric Population
    • 4.2.2 Rise in Demand for Minimally Invasive Surgery and Product Development
  • 4.3 Market Restraints
    • 4.3.1 Social Stigma Associated with the Disease and Risks and Complications from the Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Transobturator Slings
    • 5.1.2 Tension-free vaginal tape sling
    • 5.1.3 Others
  • 5.2 By End-User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgery Centers
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Coloplast Corp
    • 6.1.3 Promedon Group
    • 6.1.4 A.M.I. GmbH
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Betatech Medical
    • 6.1.7 Caldera Medical
    • 6.1.8 CR Bard Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q